Onzet Indications/Uses

Tablet: Ondansetron is a 5-HT3 antagonist with antiemetic activity. It is used in the management of nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy. It is also used for the prevention and treatment of post-operative nausea and vomiting.
Injection: Prevention of Nausea and Vomiting Associated with Initial and Repeat Courses of Emetogenic cancer Chemotherapy: Ondansetron (Onzet) Injection is indicated for the prevention of nausea and vomiting associated with initial and repeat course of emetogenic cancer chemotherapy, including high-dose cisplatin.
Ondansetron (Onzet) Injection is approved for patients aged 6 months and older.
Prevention of Postoperative Nausea and/or Vomiting: Ondansetron (Onzet) Injection is indicated for the prevention of postoperative nausea and/or vomiting. As with other antiemetics, routine prophylaxis is not recommended for patients in whom there is little expectation that nausea and/or vomiting will occur postoperatively. In patients in whom nausea and/or vomiting must be avoided postoperatively. Ondansetron (Onzet) Injection is recommended even when the incidence of postoperative nausea and/or vomiting is low. For patients who do not receive prophylactic Ondansetron (Onzet) Injection and experience nausea and/or vomiting postoperatively. Ondansetron (Onzet) Injection may be given to prevent further episodes.
Ondansetron (Onzet) Injection is approved for patients aged 1 month and older.